International Stem Cell financials at a glance

+ Portfolio

The revenue of International Stem Cell is reported as 0.00947 billion Dollars in the fiscal year 2023. The earnings were -0.57 Dollars per share in 2023, which was 0 higher than 2019. And about -0.00086 billion Dollars are reported as free cash flow in the financials of International Stem Cell 2023. No dividends were paid to the shareholders of the International Stem Cell stock OTCPK:ISCO in the financial year 2023.

$9.47M

Revenue

$-0.57

Earnings Per Share

59.16%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

9.47

Earnings Per Share

-0.57

Gross Margin %

59.16

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2019	2018	2017	2016	2013	2011
Rev.	Revenue	N/A	$9.47M	$9.47M	$11.09M	$7.46M	$7.17M	$6.15M	$4.53M
GM %	Gross Margin %	58.54%	59.16%	58.48%	63.31%	71.54%	72.87%	73.27%	64.30%
OM	Operating Margin	-2.14%	-8.51%	-44.21%	-25.85%	-50.52%	-63.10%	-,121.49%	-,250.24%
EPS	Earnings Per Share	$0.02	$-0.57	$-0.57	$-0.33	$-1.46	$-1.52	$-13.50	$-18.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0
Sha.	Shares	N/AM	8M	7.54M	7.53M	6.06M	3.95M	1.01M	0.53M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$0.10	$0.11	$-0.25	$-0.27	$-0.72	$-1.61	$-7.96	$-16.17

International Stem Cell financials at a glance

Financials

Discover